# IGM Biosciences A/S — Form D

IGM Biosciences A/S of KONGENS LYNGBY, G7, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-16. The offering totals $2.4M, of which $2.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-01-16
- Form: D
- Accession: 0001727622-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $2.1M
- Remaining: $222K
- Minimum investment: $1K
- Investors: 11
- Date of first sale: 2017-12-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-303330

## Issuer

- Name: IGM Biosciences A/S
- CIK: 0001727622
- Entity type: Corporation
- Jurisdiction: DENMARK
- Incorporated: 2017
- Address: HALDOR TOPSOES ALLE 1, KONGENS LYNGBY, G7, 2800
- Phone: 45 5339 3404

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Christina Haldor Topsoe | Director | Kongens Lyngby, G7 |
| Henrik Haldor Topsoe | Director | Kongens Lyngby, G7 |
| Jakob Haldor Topsoe | Director | Mountain View, CA |
| Hans Kornerup | Executive Officer | Kongens Lyngby, G7 |

## More

- [CIK 1727622 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1727622&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001727622-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.